Terms: = Lymphoma AND HOXD13, SPD, 3239, P35453, HOX4I AND Treatment
21 results:
1. Correlation between PD-1 and spd-L1 expression levels in peripheral blood of DLBCL patients and their clinicopathological characteristics.
Wang L; Cao C; Qiu J; Zhang J; He Q; Song L; Xie L; Ma J
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):44-50. PubMed ID: 38430041
[TBL] [Abstract] [Full Text] [Related]
2. Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Schiller GJ; Lipe BC; Bahlis NJ; Tuchman SA; Bensinger WI; Sutherland HJ; Lentzsch S; Baljevic M; White D; Kotb R; Chen CI; Rossi A; Biran N; LeBlanc R; Grosicki S; Martelli M; Gunsilius E; Špička I; Stevens DA; Facon T; Mesa MG; Zhang C; Van Domelen DR; Bentur OS; Gasparetto C
Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):e286-e296.e4. PubMed ID: 37393120
[TBL] [Abstract] [Full Text] [Related]
3. Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma.
Cheng CL; Yao CY; Huang PH; Yu CW; Fang WQ; Chuang WH; Wu SJ; Lin YJ; Hung YC; Tsai CH; Yu SC; Chou WC; Tien HF
Br J Haematol; 2023 Apr; 201(1):75-85. PubMed ID: 36480431
[TBL] [Abstract] [Full Text] [Related]
4. Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA.
Ruiz IC; Martelli M; Sehn LH; Vitolo U; Nielsen TG; Sellam G; Bottos A; Klingbiel D; Kostakoglu L
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e804-e814. PubMed ID: 35595618
[TBL] [Abstract] [Full Text] [Related]
5. Universal extracellular vesicles and PD-L1+ extracellular vesicles detected by single molecule array technology as circulating biomarkers for diffuse large B cell lymphoma.
Li JW; Shi D; Wan XC; Hu J; Su YF; Zeng YP; Hu ZJ; Yu BH; Zhang QL; Wei P; Zhou XY
Oncoimmunology; 2021; 10(1):1995166. PubMed ID: 34745768
[TBL] [Abstract] [Full Text] [Related]
6. Mutant
Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
[TBL] [Abstract] [Full Text] [Related]
7. A Systemic Protein Deviation Score Linked to PD-1
Ask EH; Tschan-Plessl A; Gjerdingen TJ; Sætersmoen ML; Hoel HJ; Wiiger MT; Olweus J; Wahlin BE; Lingjærde OC; Horowitz A; Cashen AF; Watkins M; Fehniger TA; Holte H; Kolstad A; Malmberg KJ
Med; 2021 Feb; 2(2):180-195.e5. PubMed ID: 35590201
[TBL] [Abstract] [Full Text] [Related]
8. FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of
Løndalen A; Blakkisrud J; Revheim ME; Madsbu UE; Dahle J; Kolstad A; Stokke C
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1902-1914. PubMed ID: 33196921
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological Features, treatment Strategy, and Prognosis of Primary Non-Hodgkin's lymphoma of the Duodenum: A SEER Database Analysis.
Zheng G; Wang Y; Zhao Y; Zheng Z
Can J Gastroenterol Hepatol; 2020; 2020():9327868. PubMed ID: 32399459
[TBL] [Abstract] [Full Text] [Related]
10. Serum levels of soluble programmed death-ligand 1 (spd-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ
BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467
[TBL] [Abstract] [Full Text] [Related]
11. Comparisons of
Lee I; Byun BH; Lim I; Kim BI; Choi CW; Kim KM; Shin DY; Kang HJ; Lim SM
Ann Nucl Med; 2019 Dec; 33(12):881-890. PubMed ID: 31571043
[TBL] [Abstract] [Full Text] [Related]
12. Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.
Rivas MM; Berro M; Prates MV; Yantorno S; Fiad L; Arbelbide JA; Basquiera AL; Ferini GA; García JJ; García PA; Riera L; Jarchum G; Baso A; Real J; Castro M; Jaimovich G; Martinez Rolón J; Foncuberta C; Saba S; Kusminsky G;
Bone Marrow Transplant; 2020 Jan; 55(1):117-125. PubMed ID: 31435033
[TBL] [Abstract] [Full Text] [Related]
13. Impact of serum soluble programed death ligand 1 on end of treatment metabolic response of diffuse large B cell lymphoma patients.
El-Ghammaz AMS; Gadallah HA; Kamal G; Maher MM; Mohamad MA
Clin Exp Med; 2018 Nov; 18(4):505-512. PubMed ID: 29876769
[TBL] [Abstract] [Full Text] [Related]
14. Chemotherapeutic treatment reduces circulating levels of surfactant protein-D in children with acute lymphoblastic leukemia.
Rathe M; Sorensen GL; Wehner PS; Holmskov U; Sangild PT; Schmiegelow K; Müller K; Husby S
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667327
[TBL] [Abstract] [Full Text] [Related]
15. High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.
Wang H; Wang L; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Li ZM; Lu Y
Oncotarget; 2016 May; 7(22):33035-45. PubMed ID: 27105512
[TBL] [Abstract] [Full Text] [Related]
16. Interstitial lung disease induced by alectinib (CH5424802/RO5424802).
Ikeda S; Yoshioka H; Arita M; Sakai T; Sone N; Nishiyama A; Niwa T; Hotta M; Tanaka T; Ishida T
Jpn J Clin Oncol; 2015 Feb; 45(2):221-4. PubMed ID: 25398579
[TBL] [Abstract] [Full Text] [Related]
17. Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.
Tateishi U; Tatsumi M; Terauchi T; Ishizawa K; Ogura M; Tobinai K
Cancer Sci; 2011 Feb; 102(2):414-8. PubMed ID: 21156007
[TBL] [Abstract] [Full Text] [Related]
18. An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells.
Oliveira BM; Romanha AJ; Alves TM; Viana MB; Zani CL
Braz J Med Biol Res; 2004 May; 37(5):649-58. PubMed ID: 15107925
[TBL] [Abstract] [Full Text] [Related]
19. Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates.
Griese M; Neumann M; von Bredow T; Schmidt R; Ratjen F
Eur Respir J; 2002 Nov; 20(5):1284-91. PubMed ID: 12449186
[TBL] [Abstract] [Full Text] [Related]
20. Surfactant protein D and KL-6 as serologic indicators of Pneumocystis carinii pneumonia in a child with acute lymphoblastic leukemia.
Takahashi T; Ebihara Y; Manabe A; Tsuji K; Nakamura T; Nakahata T; Iwamoto A
J Med; 2001; 32(1-2):41-51. PubMed ID: 11321887
[TBL] [Abstract] [Full Text] [Related]
[Next]
